Halma Acquires US-based Maxtec For $20 Mln – Quick Facts
Halma plc (HLMA.L), a safety, health and environmental technology group, announced Friday that it has acquired Utah, US-based Maxtec, LLC.
The cash consideration for Maxtec is $20 million or about 15.3 million pounds on a cash and debt free basis. The consideration will be funded from Halma’s existing facilities.
Maxtec is engaged in the manufacture and distribution of oxygen analysis and delivery products for use in medical and non-medical applications. Maxtec’s revenue and Adjusted EBIT for the twelve months to the end of March 2019 were $20.4 million and $1.8 million, respectively.
Maxtec will be managed as part of Halma’s Perma Pure business, whose medical dehydration products are also used in acute care units. It will become part of Halma’s Medical sector.
Maxtec’s key management team will remain with the business and it will continue to operate in its current facility.
Andrew Williams, Group Chief Executive at Halma, said, “It brings technology and a market presence that will accelerate Perma Pure’s growth in medical moisture management products and adds a new niche in oxygen analysis and delivery products, where growth is being driven by ageing populations and the increasing prevalence of heart and respiratory conditions.”
Watch | Hyundai Aura first drive and review
A video review of Hyundai Aura
Apart from an elegant body, the all-new Hyundai Aura comes with a powerful engine, whether in the turbo-petrol and the diesel variants. The compact sedan ticks many boxes in other key features as well. Watch the video to find out how it feels on the road…
Sika FY19 Profit Rises, Lifts Dividend; Sees Growth In FY20, Ahead – Quick Facts
Sika (SXYAY.PK,SKFOF.PK), a specialty chemicals company, reported Friday that its fiscal 2019 net profit increased 10.4 percent to 758.5 million Swiss francs from last year’s 687.1 million francs.
Earnings per share were 5.30 francs, up 13 percent from 4.69 francs a year ago.
Operating profit increased 11.5 percent to 1.06 billion francs, surpassing the billion-franc threshold for the first time.
EBITDA increased 20.7 percent to 1.39 billion francs.
Sales grew 14.4 percent to 8.11 billion francs from 7.09 billion francs last year. Sales grew 16.3 percent in local currencies. Organic growth reached 3.3 percent.
Further, the Board of Directors will be proposing a 12.2 percent increase in the gross dividend to 2.30 francs at the Annual General Meeting of April 21, 2020.
Looking ahead, for 2020, Sika is expecting a sales increase of more than 10 percent in local currencies, as well as an over-proportional increase in profitability due to the higher acquisition impact.
The unknown impact of the coronavirus on the development of the end markets is an element of uncertainty.
Regarding Strategy 2023, Sika said it is seeking to grow by 6-8 percent a year in local currencies by 2023. It is aiming for a higher EBIT margin of 15-18 percent from 2021 onward.
U.S. Weekly Jobless Claims Show Modest Increase
A report released by the Labor Department on Thursday showed a modest increase in first-time claims for U.S. unemployment benefits in the week ended February 15th.
The Labor Department said initial jobless claims crept up to 210,000, an increase of 4,000 from the previous week’s revised level of 206,000.
Economists had expected jobless claims to inch up to 210,000 from the 205,000 originally reported for the previous week.
Meanwhile, the report said the less volatile four-week moving average edged down to 209,000, a decrease of 3,250 from the previous week’s revised average of 212,250.
The Labor Department also said continuing claims, a reading on the number of people receiving ongoing unemployment assistance, rose by 25,000 to 1.726 million in the week ended February 8th.
The four-week moving average of continuing claims still dipped to 1,722,250, a decrease of 5,250 from the previous week’s revised average of 1,727,500.
Allianz Q4 Profit Rises; Lifts 2020 Operating Profit View
German insurance and asset management company Allianz SE (AZSEY.PK) reported that its fourth-quarter net income attributable to shareholders rose 9.5 percent to 1.86 billion euros from last year’s 1.70 billion euros, due to an improved non-operating result. Earnings per share also increased to 4.44 euros from 3.93 euros in the previous year.
The company now projects 2020 operating profit to be 12.0 billion euros, plus or minus 500 million euros, compared to the prior estimation of 11.5 billion euros, plus or minus 500 million euros.
The company said its board of management will propose a dividend of 9.60 euros per share for 2019. It is 6.7 percent higher than last year’s dividend of 9 euros and the seventh increase in a row.
The company said it will buy-back up to 1.5 billion euros of shares that is to be completed by the end of the year.
The company reported that operating profit for the fourth-quarter was 2.75 billion euros, compared to 2.77 billion euros in the prior year.
Total revenues for the quarter grew 7.0% to 35.5 billion euros from 33.2 billion euros in the prior year.
Rhoen-Klinikum FY19 Profit Down; Sees Weak EBITDA , Higher Revenues In FY20
German hospital operator Rhoen-Klinikum AG (RKKPF.PK) reported Friday that its fiscal 2019 net consolidated profit declined, as expected, to 44.5 million euros from 51.2 million euros in the previous year.
Earnings before interest, taxes, depreciation and amortisation or EBITDA was almost at the previous year’s level with 125.3 million euros. The EBITDA margin amounted to 9.6 percent.
In financial year 2019, revenues rose 5.8 percent from last year to 1.3 billion euros. Number of patients increased 1.2 percent to 860,528.
Looking ahead for fiscal 2020, the company expects revenues in the amount of 1.4 billion euros, plus or minus 5 percent. The company also expects EBITDA in the range of 72.5 million euros to 82.5 million euros.